2003-2013, a valuable study: Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in stage IV breast cancer | |
Lin, Mao[1,2]; Liang, Shuzhen[1,2]; Jiang, Feng[2]; Xu, Jiongyuan[1]; Zhu, Weibing[1]; Qian, Wei[1]; Hu, Yong[1]; Zhou, Zhanchun[1]; Chen, Jibing[1,2]; Niu, Lizhi[2] | |
2017 | |
卷号 | 183页码:37 |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4308312 |
专题 | 暨南大学 |
作者单位 | 1.[1]Jinan Univ, Fuda Canc Hosp, Dept Biotherapy Ctr, Sch Med, 2 TangDe Xi Rd, Guangzhou, Peoples R China 2.[2]Dept Fuda Canc Inst, 2 TangDe Xi Rd, Guangzhou, Peoples R China 3.[3]Peking Univ, Cent Lab Canc Hosp, Beijing, Peoples R China |
推荐引用方式 GB/T 7714 | Lin, Mao[1,2],Liang, Shuzhen[1,2],Jiang, Feng[2],et al. 2003-2013, a valuable study: Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in stage IV breast cancer[J],2017,183:37. |
APA | Lin, Mao[1,2].,Liang, Shuzhen[1,2].,Jiang, Feng[2].,Xu, Jiongyuan[1].,Zhu, Weibing[1].,...&Lv, Youyong[3].(2017).2003-2013, a valuable study: Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in stage IV breast cancer.,183,37. |
MLA | Lin, Mao[1,2],et al."2003-2013, a valuable study: Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in stage IV breast cancer".183(2017):37. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论